Aardvark Therapeutics, Inc. Common Stock (AARD) NASDAQ
4.54
+0.03(+0.67%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 286.44M |
| Enterprise Value | 239.83M |
| P/E Ratio | -1.42 |
| PEG Ratio | 0.02 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.14 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.49 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
Management Effectiveness
| Return On Assets | -0.71 |
| Return On Equity | -0.62 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -62.69M |
| Net Income | -57.59M |
| Diluted EPS | -2.64 |
Balance Sheet
| Total Cash | 91.2M |
| Total Cash/Share | 4.18 |
| Total Debt | 336,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 8.06 |
| Book Value Per Share | 3.99 |
Price History
| 52-Week Change | -53.77 |
| 52-Week High | 17.94 |
| 52-Week Low | 3.35 |
| Moving Average 50 Days | 4.83 |
| Moving Average 200 Days | 10.03 |
Statistics
| Average Volume | 307,254 |
| Shares Outstanding | 21.82M |
| % Held by Institutions | 46.75 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
